The Latest Breaking News from Life Sciences

STERIS has outpaced the broader healthcare sector over the past year and analysts are reasonably bullish on its future prospects.

Sitting in 64th position in Barchart’s Bottom 100 Stocks to Buy is Innovate Corp., a penny stock controlled by one of the Glazer family, the owners of the Tampa Bay Bucs and controlling shareholders of Manchester United. It could be a sum-of-the-parts play. Here’s why.

It is the latest effort to follow up on the prime minister’s pledge to turn the UK into a ‘science superpower’

KTR chairs meet with pharma industry leaders, WEF team

To bring together life sciences and healthcare leaders, academia, startups, regulators, investors

Flora Growth Corp. (NASDAQ: FLGC), a manufacturer and distributor of global cannabis products and brands, reported late Monday its financial and operating results for the six months ended June 30, 2022.

Here's a roundup of top developments in the biotech space over the last 24 hours:

Becton Dickinson and Co (NYSE:BDX) reported Q2 FY22 revenues of $5.01 billion, up 2.1% Y/Y (3.9% on a currency-neutral basis), better than the consensus of $4.85 billion. Revenue was driven by base revenue growth of 8.2% as reported, 10.2% currency-neutral, partially offset by the decline in COVID-only testing revenues to $214 million…

Corning Inc (NYSE:GLW) reported first-quarter FY22 core sales growth of 15% year-on-year to $3.7 billion, above the consensus of $3.57 billion. Display Technologies sales grew 11% Y/Y to $959 million, driven by a favorable glass pricing environment.   Optical Communications sales rose 28% Y/Y to $1.2 billion as 5G, broadband, and cloud computing continue…